A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia.
about
Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender DifferencesBone Mineral Density in Schizophrenia: An Update of Current Meta-Analysis and Literature Review Under Guideline of PRISMALower Bone Mineral Density at the Hip and Lumbar Spine in People with Psychosis Versus Controls: a Comprehensive Review and Skeletal Site-Specific Meta-analysisChronic Psychosocial Stress Impairs Bone Homeostasis: A Study in the Social Isolation Reared Rat.Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Bone Mineral Density as a Marker of Cumulative Estrogen Exposure in Psychotic Disorder: A 3 Year Follow-Up StudyClinical correlates of vitamin D deficiency in established psychosis.The prevalence of pain in bipolar disorder: a systematic review and large-scale meta-analysis.TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META-ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS.Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review.Lack of tolerable treatment options for patients with schizophrenia.Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidinePrevalence of osteoporosis in schizophrenia patients using the osteoporosis self-assessment tool for Asians.What are the top 10 physical activity research questions in schizophrenia?Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis.A comparison of physical fitness in patients with bipolar disorder, schizophrenia and healthy controls.Management of common adverse effects of antipsychotic medications
P2860
Q26739664-E05F115E-CC73-4068-B73E-D47FBF7361F1Q26775158-50255FD0-2349-40A1-90E2-E0A2DB92503DQ28073179-E856EDF0-F2AC-4AD4-A034-BFF226E297CEQ30380187-C94A29A0-0DE9-43A7-99A6-27DEA3FFDA89Q33878816-F33D20B9-457F-4EC5-88D6-EE1B81E99AADQ35754726-4EDD90A9-C05D-4B64-9B16-35B77F1750E8Q35756140-C6090A56-FF5C-4EF5-9647-68FDE5BDB10DQ35965185-A7FEDFD8-754B-4007-9EB1-45DA1181D76DQ38237481-0E396669-994A-49F9-A5C4-7C9CF610E9B0Q38538401-326181F6-93D1-42ED-B4A6-F74B74FE99ABQ38778145-A361D0B7-83FB-48BE-B2A5-D4B870885FA6Q38994958-4A9B6680-4C1D-48A1-ACE9-D4C8C11B6794Q42120078-2CB0BE89-87C0-491B-ACE6-46D3E8CCC886Q42375259-29C32B6E-8B59-4CFC-8800-654326A0BB8BQ45027349-E183B04B-F399-4E69-B11C-A980B385E92FQ46179486-E2D2C805-7F50-45B5-B2DF-F29C837C7634Q47557751-6D0CD130-0154-44B3-8B22-F2C755BA1936Q48890919-B4C985FC-F00F-46C1-B4C4-67FCB3C48F11Q58760350-BCC0A26D-9F71-4789-815E-537CFB315D98
P2860
A meta-analysis of prevalence estimates and moderators of low bone mass in people with schizophrenia.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A meta-analysis of prevalence ...... in people with schizophrenia.
@en
type
label
A meta-analysis of prevalence ...... in people with schizophrenia.
@en
prefLabel
A meta-analysis of prevalence ...... in people with schizophrenia.
@en
P2093
P2860
P50
P356
P1476
A meta-analysis of prevalence ...... in people with schizophrenia.
@en
P2093
C U Correll
D Vancampfort
P2860
P304
P356
10.1111/ACPS.12313
P407
P577
2014-07-10T00:00:00Z